Venlafaxine
Venlafaxine is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Venlafaxine; Generic name: VENLAFAXINE; Manufacturer: Modavar Pharmaceuticals LLC.
| Brand name | Venlafaxine |
|---|---|
| Generic name | VENLAFAXINE |
| Manufacturer | Modavar Pharmaceuticals LLC |
| Used for | 1 INDICATIONS AND USAGE Venlafaxine extended-release tablets are a selective serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for: Major Depressive Disorder (MDD) ( 1.1 ) Social Anxiety Disorder (SAD) ( 1.2 ) 1.1 Major Depressive Disorder Venlafaxine extended-release tablets are indicated for the treatment of major depressive disorder (MDD). Efficacy of venlafaxine in MDD was shown in both short-term trials and a longer-term trial in MDD [see Clinical Studies ( 14.1 )] . A major depressive episode (DSM-IV) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed mood or the loss of interest or pleasure in nearly all activities, represent |
| Dosage | 2 DOSAGE AND ADMINISTRATION Venlafaxine extended-release tablets should be administered in a single dose with food either in the morning or in the evening at approximately the same time each day. Each tablet should be swallowed whole with fluid and not divided, crushed, chewed, or placed in water. Initial Treatment (2.1) Indication Starting Dose Dose Increase Maximum Dose Major Depressive Disorder 75 mg/day (in some patients, 37.5 mg/day for 4 to 7 days) 75 mg/day increments at intervals of 4 da |
| Warnings | BOXED WARNING WARNING: SUICIDALITY AND ANTIDEPRESSANT DRUGS Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of Major Depressive Disorder (MDD) and other psychiatric disorders. Anyone considering the use of venlafaxine extended-release tablets or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did |
| Active ingredient(s) | VENLAFAXINE HYDROCHLORIDE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=14b38374-7287-47dd-8ef9-e88bd5b23a26 |